SCHEMBL18172029

SCHEMBL18172029

N#CC(C(N)=O)c1ccc(C(F)(F)F)cn1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.50
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ABL1 P00519 1/20 0.39
PTGS1 P23219 1/20 0.39
PDE2A O00408 2/20 0.37
SCN9A Q15858 3/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 2/20 0.35
POLB P06746 2/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028822 0.80 KMT2A (0.40) KMT2ALMNAKDM4EPDE2AMAPK1
SCHEMBL27466228 0.77 KMT2A (0.54) KMT2ALMNAKDM4EABL1PTGS1
SCHEMBL18172158 0.77 S1PR3 (0.43)
SCHEMBL22758118 0.76 KMT2A (0.53) KMT2ALMNAKDM4EABL1PTGS1
SCHEMBL18172003 0.74 ALDH1A1 (0.41) KMT2ALMNAKDM4EMAPK1ALDH1A1
SCHEMBL22499955 0.71 KMT2A (0.50) KMT2ALMNAKDM4EABL1PTGS1
SCHEMBL18172071 0.71 PDE2A (0.49) KDM4EPDE2ASCN9AALDH1A1GAA
SCHEMBL28999785 0.71 KMT2A (0.50) KMT2ALMNAKDM4EABL1PTGS1
SCHEMBL3206362 0.71 ALDH1A1 (0.46) KMT2AKDM4EPTGS1PDE2ASCN9A
SCHEMBL26925870 0.70 KMT2A (0.47) KMT2ALMNAKDM4EABL1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286178-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS Almirall S.A. (ES) 2018-02-28 EP disclosed
WO-2016170009-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS ALMIRALL, S.A. (ES) 2016-10-27 WO disclosed